US Edition
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth
- Dr. Di Hong has been appointed as the Chief Executive Officer of Nona Biosciences to lead its growth and technological innovation.
- Dr. Jingsong Wang, Chairman of Nona Biosciences, stated that Dr. Hong's leadership experience makes him well-suited for the role.
- Dr. Di Hong expressed his honor in joining Nona Biosciences, a leading biotech company.
- Nona Biosciences aims to enhance its biopharmaceutical innovation from 'Idea to IND' while developing a more open innovation ecosystem.
66 Articles
66 Articles
keenesentinel.com
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth
CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced the appointment of Dr. Di Hong as Chief Executive Officer (CEO).…
Nona Biosciences Appoints Dr. Di Hong CEO
Nona Biosciences, a global biotechnology company providing integrated solutions from “Idea to IND” (I to ITM), today announced the appointment of Dr. Di Hong as Chief Executive Officer (CEO). Dr. Hong will be based in Shanghai and report directly to Dr. Jingsong Wang, Chairman of Nona Biosciences. This milestone reflects a pivotal step in Nona’s journey to accelerate innovation in antibody discovery and development. Leveraging its proprietary in…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
